Knowledge Center

Article / Jun 08, 2009

A Well-Integrated Sideline. Deal to supply an inhaler device to Daiichi Sankyo marks a big victory for Hovione

Authors:
Source:
C&EN, 8 June, 2009

Spirits were high as Portugal-based executives from Hovione arrived in Cork, Ireland, in late April for the inauguration of the company's newly acquired pharmaceutical chemical facility. The acquisition, from Pfizer, closed on April 8, the same day as the company's 50th anniversary.

Related links

Read article here

Also in the Knowledge Center

Related Content

Dry Powder Inhalation formulation development

Hovione has considerable inhalation experience that allows us to implement strategies including conventional carrier based, neat (drug-alone) or composite particle formulations.

Page
Read more

API

Hovione inhalation grade APIs bring unique controlled performance to your formulation.

Page
Read more

60 Years

In 2019, Hovione celebrates its 60th Anniversary.

Page
Read more